CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31
Altamira Therapeutics Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)
Close on Oct 19, 2026
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 10, 2024(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Dec 13, 2023 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Nov 30, 2022(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Oct 25, 2022 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Aug 15, 2019(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| May 1, 2019 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Mar 14, 2019(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Mar 14, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |